Showing results 1 to 20 of 24
next >
Issue Date | Title | Author(s) |
2013-04-12 | Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells | Jaiswal, R; Luk, F; Dalla, PV; Grau, GER; Bebawy, M |
2013-12-17 | Cell-derived microparticles: New targets in the therapeutic management of disease | Roseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M |
2013-10-01 | Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21<sup>st</sup> century | Lee, WH; Loo, CY; Bebawy, M; Luk, F; Mason, RS; Rohanizadeh, R |
2015-01-01 | Fabrication of curcumin micellar nanoparticles with enhanced anti-cancer activity | Lee, WH; Bebawy, M; Loo, CY; Luk, F; Mason, RS; Rohanizadeh, R |
2015-02-15 | Functional translation of total RNA packaged in microparticles shed from multidrug resistant cancer cells | Lu, JF; Pokharel, D; Luk, F; Bebawy, M |
2014-01-01 | Inhibition of the multidrug resistance P-glycoprotein: Time for a change of strategy? | Callaghan, R; Luk, F; Bebawy, M |
2016-01-01 | Isolation of Human CD138<sup>+</sup> Microparticles from the Plasma of Patients with Multiple Myeloma | Krishnan, SR; Luk, F; Brown, RD; Suen, H; Kwan, Y; Bebawy, M |
2012-01 | Microparticle Conferred MicroRNA Profiles - Implications In The Transfer And Dominance Of Cancer Traits | Jaiswal, R; Luk, F; Gong, J; Mathys, J; Grau, G; Bebawy, M |
2012-06-08 | Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits | Jaiswal, R; Luk, F; Gong, J; Mathys, JM; Grau, GER; Bebawy, M |
2012-01 | Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. | Jaiswal, R; Luk, F; Gong, J; Mathys, J-M; Grau, GER; Bebawy, M |
2013-01 | Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance | Gong, J; Luk, F; Jaiswal, R; George, AM; Grau, G; Bebawy, M |
2013-12-05 | Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance | Gong, J; Luk, F; Jaiswal, R; George, AM; Grau, GER; Bebawy, M |
2015-08-01 | Microparticles as novel prognostic markers in multiple myeloma | Rajeev Krishnan, S; Bebawy, M; Brown, RD; Luk, F; Kwan, Y |
2015-02-15 | Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancer | Gong, J; Luk, F; Jaiswal, R; Bebawy, M |
2015-04 | Microparticles in cancer: A review of recent developments and the potential for clinical application | Gong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M |
2015-04-01 | Microparticles in cancer: A review of recent developments and the potential for clinical application | Gong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M |
2013-09-02 | Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways | Lu, JF; Luk, F; Gong, J; Jaiswal, R; Grau, GER; Bebawy, M |
2014-01-01 | Microparticles mediate the intercellular regulation of microRNA-503 and proline-rich tyrosine kinase 2 to alter the migration and invasion capacity of breast cancer cells | Gong, J; Luk, F; Jaiswal, R; Bebawy, M |
2016-07-01 | Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review) | Krishnan, SR; Jaiswal, R; Brown, RD; Luk, F; Bebawy, M |
2015-09-01 | Multiple myeloma: A novel tailor-made therapeutic management. | Krishnan, SR; Bebawy, M; Luk, F; Brown, RD; Kwan, YL |